Pothast CR, Hofsink Q, Haggenburg S, Dijkland RC, van de Meent M, van Dijk K, Bhoekhan MS, Haverkate NJ, van Meerloo J, Falkenburg JF, de Groen RA, Broers AE, van Doesum JA, van Binnendijk RS, den Hartog G, Lissenberg-Witte BI, Kater AP, Smits GP, Wouters D, van Leeuwen EM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, van Baarle D, de Vries RD, van Meerten T, Mutsaers PG, Goorhuis A, Nijhof IS, Hazenberg MD, Heemskerk MH, Rutten CE, study team CK. T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2799-805. Available from: https://haematologica.org/article/view/12080